中国神经再生研究(英文版) ›› 2013, Vol. 8 ›› Issue (3): 197-207.doi: 10.3969/j.issn.1673-5374.2013.03.001
• 原著:脑损伤修复保护与再生 • 下一篇
收稿日期:
2012-09-10
修回日期:
2012-11-20
出版日期:
2013-01-25
发布日期:
2013-01-25
Yulian Jin1, 2, Liuyi Dong1, Changqing Wu1, Jiang Qin1, Sheng Li1, Chunyan Wang3, Xu Shao4, Dake Huang5
Received:
2012-09-10
Revised:
2012-11-20
Online:
2013-01-25
Published:
2013-01-25
Contact:
Liuyi Dong, Ph.D., M.D., Associate professor, Department of Pharmacology, Key Laboratory of Anti- inflammatory and Immunopharmacology, Ministry of Education; Key Laboratory of Chinese Medicine Research and Development, State Administration of Traditional Chinese Medicine, Anhui Medical University, Hefei 230032, Anhui Province, China, dongly061@yahoo.com.cn.
About author:
Yulian Jin★, Master, Chief physician, Master’s supervisor.
Yulian Jin and Liuyi Dong contributed equally to this work.
Supported by:
This project was supported by a grant from the Major Programs of Anhui Science and Technology Special Funds, No. 08010302099; and the Doctor Funds of Anhui Medical University, No. XJ200813.
摘要:
实验在中药传统名方补阳还五汤的基础上进行工艺创新,分离出的其有效部位群,主要包括黄芪总皂苷、赤芍总苷、红花总黄酮,应用体内和体外实验验证其对脑缺血再灌注损伤的保护作用。体内实验结果显示50-200mg/kg的补阳还五汤有效部位可减小脑缺血再灌注大鼠的脑组织梗死体积及病理损伤,并能明显抑制缺血周边区、皮质区及海马区神经元肿瘤坏死因子α和核因子κB蛋白的表达,促进Nestin蛋白的表达;以200mg/kg的补阳还五汤有效部位作用最明显,与100 mg/kg的银杏叶提取物作用相当。体外实验发现,10-100mg/L的补阳还五汤有效部位能够抑制连二亚硫酸钠诱导的海马神经元损伤,提高其存活率,降低神经元上清液中乳酸脱氢酶活性和丙二醛含量,减少细胞凋亡;以100mg/L的补阳还五汤有效部位作用最明显,与100mg/L的银杏叶提取物作用相当。提示补阳还五汤有效部位对脑缺血再灌注损伤具有明显的保护作用,其机制与抑制脑缺血再灌注后炎症反应及细胞凋亡有关。
. 补阳还五汤有效部位减轻脑缺血再灌注损伤[J]. 中国神经再生研究(英文版), 2013, 8(3): 197-207.
Yulian Jin, Liuyi Dong, Changqing Wu, Jiang Qin, Sheng Li, Chunyan Wang, Xu Shao, Dake Huang. Buyang Huanwu Decoction fraction protects against cerebral ischemia/reperfusion injury by attenuating the inflammatory response and cellular apoptosis[J]. Neural Regeneration Research, 2013, 8(3): 197-207.
[1] Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurology. 2007;6(5):407-413.http://www.sciencedirect.com/science/article/pii/S1474442207700790 [2] Hohnloser SH, Duray GZ, Baber U, et al. Prevention of stroke in patients with atrial fibrillation: current strategies and future directions. European Heart J (Supplements). 2008;10:4-10.http://eurheartj.oxfordjournals.org/search?fulltext=Prevention+of+stroke+in+patients+with+atrial+fibrillation%3A+current+strategies+and+future+directions&submit=yes&x=15&y=8[3] Alexandrov AV, Hall CE, Labiche LA, et al. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke. Stroke. 2004;35(2):449-452.http://stroke.ahajournals.org/content/35/2/449.long [4] Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood–brain barrier disruption. Stroke. 2004;35(11 Suppl 1):2659-2661.http://stroke.ahajournals.org/content/35/11_suppl_1/2659.long [5] Wang GX, Li GR, Wang YD, et al. Characterization of neuronal cell death in normal and diabetic rats following exprimental focal cerebral ischemia. Life Sci. 2001;69(23):2801-2810.http://www.sciencedirect.com/science/article/pii/S0024320501013546 [6] Bråtane BT, Walvick RP, Corot C, et al. Characterization of gadolinium-based dynamic susceptibility contrast perfusion measurements in permanent and transient MCAO models with volumetric based validation by CASL. J Cereb Blood Flow Metab. 2010;30(2):336-342.http://www.nature.com/jcbfm/journal/v30/n2/full/jcbfm2009218a.html [7] Henninger N, Sicard K, Schmidt K, et al. Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke. 2006;37(5):1283-1287.http://stroke.ahajournals.org/content/37/5/1283.long [8] Hua Q, Zhu XL, Li PT, et al. Refined Qing Kai Ling, traditional Chinese medicinal preparation, reduces ischemic stroke-induced infarct size and neurological deficits and increases expression of endothelial nitric oxide synthase. Biol Pharm Bull. 2008;31(4):633-637.https://www.jstage.jst.go.jp/article/bpb/31/4/31_4_633/_article [9] Chen J, Zeng YY, Zeng HL, et al. Inhibition on inflammatory cytokine expressions in heart and lung from brain death rats pretreated with Buyang Huanwu Decoction. Zhong Cao Yao. 2010;41(5):757-761.http://www.cnki.net/KCMS/detail/detail.aspx?QueryID=12&CurRec=1&DbCode=CJFQ&dbname=CJFDLAST2010&filename=ZCYO201005026&urlid=&yx=&uid=WEEvREcwSlJHSldRa1Fhc2JHY29LbmxqNHpJeGJmYXhneE1SYkEvUXludmVmQWlHbGNvVWcrTndDZ0p6L09NPQ==[10] Zhang SP, Liang Y, Deng CQ. Effect of Buyang Huanwu Decoction and its active fractions on caspase expression after cerebral ischemia-reperfusion in rats. Zhong Cao Yao. 2006;37(7):1041-1045.http://www.cnki.net/KCMS/detail/detail.aspx?QueryID=16&CurRec=1&DbCode=CJFQ&dbname=CJFD0608&filename=ZCYO200607034&urlid=&yx=&uid=WEEvREcwSlJHSldRa1Fhc2JHY29LbmxqNHpJeGJmYXhneE1SYkEvUXludmVmQWlHbGNvVWcrTndDZ0p6L09NPQ==[11] Liu BY, Cai GX, Liu W, et al. Effect of Buyang Huanwu Decoction on vascular endothelial growth factor and its receptor Flk1 in rats after focal cerebral ischemia. Zhong Cao Yao. 2007;38(3):394-397.http://www.cnki.net/KCMS/detail/detail.aspx?QueryID=20&CurRec=1&DbCode=CJFQ&dbname=CJFD0608&filename=ZCYO200703028&urlid=&yx=&uid=WEEvREcwSlJHSldRa1Fhc2JHY29LbmxqNHpJeGJmYXhneE1SYkEvUXludmVmQWlHbGNvVWcrTndDZ0p6L09NPQ== [12] Sun J, Bi Y, Guo L, et al. Buyang Huanwu Decoction promotes growth and differentiation of neural progenitor cells: using a serum pharmacological method. J Ethnopharmacol. 2007;113(2):199-203.http://www.sciencedirect.com/science/article/pii/S0378874107002656 [13] Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184(1-2):53-68.http://www.sciencedirect.com/science/article/pii/S0165572806004693 [14] Pan W, Kastin AJ. Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog Neurobiol. 2007;83(6):363-374.http://www.sciencedirect.com/science/article/pii/S0301008207001463 [15] Mecca AP, O'Connor TE, Katovich MJ, et al. Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion. Exp Physiol. 2009;94(8):937-946.http://ep.physoc.org/content/94/8/937.long [16] Dijkhuizen RM, Knollema S, Van der Worp HB, et al. Dynamics of cerebral tissue injury and perfusion after temporary hypoxia-ischemia in the rat: evidence for region-specific sensitivity and delayed damage. Stroke. 1998;29(3):695-704.http://stroke.ahajournals.org/content/29/3/695.long [17] Zhao LD, Wang JH, Jin GR, et al. Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats--time window and mechanism. J Ethnopharmacol. 2012;140(2):339-344.http://www.sciencedirect.com/science/article/pii/S0378874112000396 [18] Jiang W, Zhang S, Fu F, et al. Inhibition of nuclear factor-κB by 6-O-acetyl shanzhiside methyl ester protects brain against injury in a rat model of ischemia and reperfusion. J Neuroinflammation. 2010;7:55.http://www.jneuroinflammation.com/content/7/1/55 [19] Huang CY, Fujimura M, Noshita N, et al. SOD1 downregulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2001;21(2):163-173.http://www.nature.com/jcbfm/journal/v21/n2/full/9591050a.html [20] Stephenson D, Yin T, Smalstig EB, et al. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab. 2000;20(3):592-603.http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=QG1Tp4QJyG1W9QgNL8L7PvwhlJMYRGZ31dnbLqSSJMQhGSYDzvnh!755119086!181195629!8091!-1?sid=WKPTLP:landingpage&an=00004647-200003000-00017 [21] Pandya JD, Sullivan PG, Pettigrew LC. Focal cerebral ischemia and mitochondrial dysfunction in the TNFα-transgenic rat. Brain Res. 2011;1384:151-160.http://www.sciencedirect.com/science/article/pii/S0006899311002332 [22] Jin K, Mao X, Xie L, et al. Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab. 2010;30(3):534-544.http://www.nature.com/jcbfm/journal/v30/n3/full/jcbfm2009219a.html [23] Yu Z, Liu J, Guo S, et al. Neuroglobin-overexpression Alters Hypoxic Response Gene Expression in Primary Neuron Culture Following Oxygen Glucose Deprivation. Neuroscience. 2009;162(2):396-403.http://www.sciencedirect.com/science/article/pii/S030645220900671X [24] Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407(6805):770-776.http://www.nature.com/nature/journal/v407/n6805/full/407770a0.html [25] Schreihofer DA, Redmond L. Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience. 2009;158(2):602-609.http://linkinghub.elsevier.com/retrieve/pii/S0306-4522(08)01493-0 [26] Ano Y, Sakudo A, Kimata T, et al. Oxidative damage to neurons caused by the induction of microglial NADPH oxidase in encephalomyocarditis virus infection. Neurosci Lett. 2010;479(1):39-43.http://www.sciencedirect.com/science/article/pii/S0304394009015213 [27] Yin WL, He JQ, Hu B, et al. Hydrogen sulfide inhibits MPP+-induced apoptosis in PC12 cells. Life Sci. 2009;85(7-8):269-275.http://linkinghub.elsevier.com/retrieve/pii/S0024-3205(09)00264-1 [28] Stemberger J, Witt V, Printz D, et al. Novel single-platform multiparameter FCM analysis of apoptosis: Significant differences between wash and no-wash procedure. Cytometry A. 2010;77(11):1075-1081.http://dx.doi.org/10.1002/cyto.a.20976 [29] Zhang X, Chen J, Davis B, et al. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo. Arch Pathol Lab Med. 1999;123(10):921-927.http://www.archivesofpathology.org/doi/full/10.1043/0003-9985(1999)123%3C0921:HIAIHC%3E2.0.CO;2 [30] Niizuma K, Endo H, Nito C, et al. Potential role of PUMA in delayed death of hippocampal CA1 neurons after transient global cerebral ischemia. Stroke. 2009;40(2):618-625.http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=19095966 [31] Guidance Suggestions for the Care and Use of Laboratory Animals. The Ministry of Science and Technology of the People’s Republic of China. 2006-09-30.[32] Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91.http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=2643202 [33] Zierath D, Hadwin J, Savos A, et al. Anamnestic recall of stroke-related deficits: an animal model. Stroke. 2010;41(11):2653-2660.http://www.cnki.com.cn/Article/CJFDTotal-SJZY201212008.htm [35] Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472-476.http://stroke.ahajournals.org/content/17/3/472.long [36] Swanson RA, Morton MT, Tsao WG, et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Met. 1990;10(2):290-293.http://www.nature.com/jcbfm/journal/v10/n2/abs/jcbfm199047a.html [37] Liang H, Liu P, Wang Y, et al. Protective effects of alkaloid extract from Leonurus heterophyllus on cerebral ischemia reperfusion injury by middle cerebral ischemic injury (MCAO) in rats. Phytomedicine. 2011;18(10):811-818. http://www.sciencedirect.com/science/article/pii/S0944711311000432 [38] Isayama K, Pitts LH, Nishimura MC. Evaluation of 2,3,5- triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke. 1991;22(11):1394-1398.http://stroke.ahajournals.org/content/22/11/1394.long [39] Li YL, Zhao L, Li L. Protective effect of diphenyl ethylene glycoside on hippocampal neuron cells ischemic injury model rats. Zhongguo Yaofang. 2006;17(1):12-14.http://www.cnki.net/KCMS/detail/detail.aspx?QueryID=24&CurRec=1&DbCode=CJFQ&dbname=CJFD0608&filename=ZGYA200601006&urlid=&yx=&uid=WEEvREcwSlJHSldRa1Fhc2JHY29LbmxqNHpJeGJmYXhneE1SYkEvUXludmVmQWlHbGNvVWcrTndDZ0p6L09NPQ==[40] Zhang LL, Xue Y, Mark K. Minocycline provides neuroprotection against glutamate neurotoxicity in HT22 cells. Int J Emerg and Crit Care Med. 2005;2:978-981.http://en.cnki.com.cn/Article_en/CJFDTotal-JWZB200506008.htm [41] Li L, Lau BH. A simplified in vitro model of oxidant injury using vascular endothelial cells. In Vitro Cell Dev Biol Anim. 1993;29A(7):531-536.http://www.ncbi.nlm.nih.gov/pubmed/8354664#[42] Zhuang H, Pin S, Li X, et al. Regulation of heme oxygenase expression by cyclopentenone prostaglandins. Exp Biol Med. 2003;228(5):499-505.http://ebm.rsmjournals.com/content/228/5/499.long[43] Jin Y, Yan EZ, Fan Y, et al. Neuroprotection by sodium ferulate against glutamate-induced apoptosis is mediated by ERK and PI3 kinase pathways. Acta Pharmacol Sin. 2007;28(12):1881-1890.http://www.nature.com/aps/journal/v28/n12/full/aps2007230a.html |
[1] | . 脑源性神经营养因子及相关酶和受体在脑缺氧缺血损伤后起重要作用[J]. 中国神经再生研究(英文版), 2021, 16(8): 1453-1459. |
[2] | . 丰富环境联合法舒地尔抑制海马CA1区神经元死亡减轻记忆障碍[J]. 中国神经再生研究(英文版), 2021, 16(8): 1460-1466. |
[3] | . 抑制一氧化氮合酶可加重糖尿病合并创伤性脑损伤大鼠的脑损伤程度[J]. 中国神经再生研究(英文版), 2021, 16(8): 1574-1581. |
[4] | . 二甲精氨酸二甲胺水解酶2 (-449 G/C) G等位基因与中国东北地区脑白质疏松发病呈正相关:一项组间配对病例对照双盲研究[J]. 中国神经再生研究(英文版), 2021, 16(8): 1592-1597. |
[5] | . 蝶翅应用于临床组织工程化神经移植材料的生物相容性和安全性[J]. 中国神经再生研究(英文版), 2021, 16(8): 1606-1612. |
[6] | . 坐骨神经损伤模型大鼠早期神经修复相关蛋白的自然变化[J]. 中国神经再生研究(英文版), 2021, 16(8): 1622-1627. |
[7] | . 神经基质膜包裹周围神经损伤的安全和有效性:一项随机单盲多中心临床试验[J]. 中国神经再生研究(英文版), 2021, 16(8): 1652-1659. |
[8] | . 促胰岛素多肽双受体激动剂DA-CH5对帕金森病大鼠神经元的神经保护作用优于exendin-4[J]. 中国神经再生研究(英文版), 2021, 16(8): 1660-1670. |
[9] | . 抑制LncRNA-5657表达可缓解脓毒症脑病大鼠大脑海马中的炎症反应[J]. 中国神经再生研究(英文版), 2021, 16(7): 1288-1293. |
[10] | . 质谱法鉴定红细胞中潜在的脊髓损伤氧化应激生物标志物[J]. 中国神经再生研究(英文版), 2021, 16(7): 1294-1301. |
[11] | . 硫化氢可增强帕金森病小鼠模型的成年神经发生[J]. 中国神经再生研究(英文版), 2021, 16(7): 1353-1358. |
[12] | . 常压氧可减轻缺血性脑卒中的高糖酵解[J]. 中国神经再生研究(英文版), 2021, 16(6): 1017-1023. |
[13] | . microRNA-670可通过Yap通路加剧脑缺血再灌注损伤[J]. 中国神经再生研究(英文版), 2021, 16(6): 1024-1030. |
[14] | . P53诱导糖酵解和凋亡调节因子可减轻缺氧缺血小胶质细胞焦亡和缺血性脑损伤[J]. 中国神经再生研究(英文版), 2021, 16(6): 1037-1043. |
[15] | . Apelin-13抑制脑缺血再灌注损伤后的细胞凋亡和过度自噬[J]. 中国神经再生研究(英文版), 2021, 16(6): 1044-1051. |
A randomized, observational, controlled animal experiment.
This experiment was performed at the Department of Pharmacology,
Drugs and reagents
BHDF containing total astragalosides 51%, total paeony glycoside 12%, and carthamus tinctorius flavonoids 8% was provided by
Ginkgo biloba extract (tablets; 2.4 mg/pill; approval No. GYZZ Z20028024; lot No. 080201) was provided by the Herb Production Factory of Ningbo City (
Animals
Ninety-six healthy adult male Sprague-Dawley rats aged 6–8 weeks and weighing 250–320 g were used. The animals were obtained from the Experimental Animal Center of Anhui Medical University (License No. SCXK (Wan) 2005-001). The animals were housed in clear plexiglas cages with stainless steel wire lids and filter tops, in a temperature-controlled (20–24°C) room. Sprague-Dawley rats were maintained on a 12-hour light/dark cycle (lights on at 7:00 a.m.). Rats were tested during the light phase of the light/dark cycle. All experimental procedures were in accordance with the Guidance Suggestions for the Care and Use of Laboratory Animals, formulated by the Ministry of Science and Technology of China[31].
Methods
In vivo experiments
Establishment of the rat middle cerebral artery occlusion model: Rats were anesthetized with an intraperitoneal injection of chloral hydrate (10% (w/v), 0.3 mL/100 g), then fixed in a supine position. After removing the fur around the neck, a midline incision was performed at the cervical region. The middle cerebral artery occlusion model was performed as previously described in detail with slight modifications[32-34]. With the tip rounded by heating near a flame, a length of 20.0–22.0 mm of 3-0 surgical monofilament nylon suture was inserted through the right common carotid arteries into the internal carotid artery until it blocked the origin of the middle cerebral artery. Rats were subjected to 2 hours of focal ischemia followed by 22 hours of reperfusion and were allowed to survive for 24 hours. The suture was not advanced to occlude the middle cerebral artery in the sham group. Rectal temperature was maintained at 37°C with air conditioning throughout the surgical procedure. Finally, animals were allowed to regain consciousness and were maintained at a room temperature of 25°C with free access to food and water. Neurological symptoms were examined and only rats demonstrating circling contralateral to the middle cerebral artery occlusion, detection of hemiplegia and abnormal posture[35] were included in the study. All rats were euthanized 24 hours after ischemia.
Drug treatment: BHDF (50, 100, 200 mg/kg; reference to the pre-experiment) or Ginkgo biloba extract (100 mg/kg) were administered to the appropriate treatment group by gavage for 7 days (once a day). Drugs were administered 7 days prior to undergoing middle cerebral artery occlusion. Animals in the sham group and the ischemia/reperfusion group were administered the same volume (1 mL/100 g) of 0.9% (w/v) saline by gavage.
Measurement of infarct volume: The rats were given an overdose of chloral hydrate and decapitated. Brains were quickly removed, rinsed in cold PBS, placed at –80°C for 3 minutes and sliced into 2 mm thick coronal sections. Tissue sections were incubated for 30 minutes at 37°C in a solution of 2% (w/v) 2,3,5-triphenyltetrazolium chloride (Sigma, St. Louis, MO, USA) in PBS in the dark. The borders of the infarct in each brain slice were outlined and the area quantified using NIH image J software. To correct for brain swelling, the infarct area was determined by subtracting the area of undamaged tissue in the left hemisphere from that of the intact contralateral hemisphere. Infarct volume was calculated by integrating the infarct areas for all slices of each brain[36]. Infarct volume ratio was calculated according to the following formula: Infarct volume ratio = (Σ infarct area × thickness)/(Σ brain slices area × thickness) × 100%.
Preparation of brain samples: middle cerebral artery occluded rats were anesthetized and perfused through the heart, first with PBS, and then with PBS containing 4% (w/v) paraformaldehyde. Rat brains were removed rapidly, and then fixed with 10% (v/v) formalin and embedded in paraffin blocks. Sections from infracted area of each group were sliced into 4-μm-thick slices using a microtome (RM-2145; Leica Slicer,
Immunohistochemical staining: Immunohistochemical staining was used to determine the protein expression of NF-κB, TNF-α and nestin. A commercially available avidin-biotin-peroxidase complex staining kit (Santa Cruz Biotechnology,
In vitro experiments
HT22 hippocampal neuronal cell cultures: HT22 cells (provided by
Oxygen-glucose deprivation model: HT22 hippocampal neurons in the logarithmic growth phase were used for all experiments. Sodium dithionite (1 mM; Wuxi Zhanwang Chemical Reagent Co., Ltd.,
Assessment of cell supernatant: Supernatants were collected to measure lactate dehydrogenase release and malondialdehyde content. Lactate dehydrogenase release was used to measure neurotoxicity[41]. Lactate dehydrogenase is a cytoplasmic enzyme released from cells with compromised cell membranes. Malondialdehyde can induce cell damage in various ways and levels reflect the content of free radicals produced by lipid peroxidation[41]. Lactate dehydrogenase activity and malondialdehyde content were detected using a colormetric reaction, which was read at an absorbance of 440 and 532 nm, respectively, using a microplate reader (Haimen Boyang,
The MTT assay: Cell survival was assayed using the microculture tetrazolium method[42]. Approximately 105 to 106 cells/well were dispensed within 96-well culture plates in 10 μL volumes. In each of the above cultured wells, 10 μL of MTT working solution (Sigma) was added to every well, and then incubated continuously for 4 hours. All culture medium supernatant was removed from the wells and then each of the plates was replaced with 100 μL of dimethyl sulfoxide (Sigma). The absorbance value of each well was measured using a microplate reader (Haimen Boyang) at 550 nm. Cell survival rate was calculated according to the following formula: Cell survival rate = absorbance value of observed group/absorbance value of control group × 100%.
Nuclear staining for the assessment of apoptosis: For quantification of apoptosis-related DNA fragments, we used Hoechst 33342 (Shanghai Shize Biological Technology Co., Ltd.,
Flow cytometry analysis of apoptosis: After cells were treated and collected, HT22 cells were digested with trypsin (2.5 g/L; Difco,
Statistical analysis
All data were expressed as mean ± SD, and were analyzed using SPSS 15.0 for Windows software (SPSS,
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||